201 related articles for article (PubMed ID: 17188149)
1. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.
Sywak M; Cornford L; Roach P; Stalberg P; Sidhu S; Delbridge L
Surgery; 2006 Dec; 140(6):1000-5; discussion 1005-7. PubMed ID: 17188149
[TBL] [Abstract][Full Text] [Related]
2. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
[TBL] [Abstract][Full Text] [Related]
3. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique.
Grodski S; Cornford L; Sywak M; Sidhu S; Delbridge L
ANZ J Surg; 2007 Apr; 77(4):203-8. PubMed ID: 17388820
[TBL] [Abstract][Full Text] [Related]
4. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.
Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM
Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539
[TBL] [Abstract][Full Text] [Related]
5. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
Alvarado R; Sywak MS; Delbridge L; Sidhu SB
Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
[TBL] [Abstract][Full Text] [Related]
6. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
[TBL] [Abstract][Full Text] [Related]
7. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
[TBL] [Abstract][Full Text] [Related]
8. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone.
Roh JL; Park JY; Park CI
Ann Surg; 2007 Apr; 245(4):604-10. PubMed ID: 17414610
[TBL] [Abstract][Full Text] [Related]
9. Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer.
Low TH; Delbridge L; Sidhu S; Learoyd D; Robinson B; Roach P; Sywak M
Ann Surg Oncol; 2008 Oct; 15(10):2827-32. PubMed ID: 18636294
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of endoscopic thyroidectomy versus conventional open thyroidectomy in papillary thyroid microcarcinoma (PTMC) patients.
Jeong JJ; Kang SW; Yun JS; Sung TY; Lee SC; Lee YS; Nam KH; Chang HS; Chung WY; Park CS
J Surg Oncol; 2009 Nov; 100(6):477-80. PubMed ID: 19653245
[TBL] [Abstract][Full Text] [Related]
11. Central lymph node metastases in unilateral papillary thyroid microcarcinoma.
Lim YC; Choi EC; Yoon YH; Kim EH; Koo BS
Br J Surg; 2009 Mar; 96(3):253-7. PubMed ID: 19224514
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
13. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
Lang BH; Wong KP; Wan KY; Lo CY
Ann Surg Oncol; 2012 Jan; 19(1):60-7. PubMed ID: 21681379
[TBL] [Abstract][Full Text] [Related]
14. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma.
Farrag TY; Agrawal N; Sheth S; Bettegowda C; Ewertz M; Kim M; Tufano RP
Head Neck; 2007 Dec; 29(12):1069-74. PubMed ID: 17563908
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
16. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer.
Schuff KG; Weber SM; Givi B; Samuels MH; Andersen PE; Cohen JI
Laryngoscope; 2008 May; 118(5):768-75. PubMed ID: 18197134
[TBL] [Abstract][Full Text] [Related]
18. Routine bilateral central lymph node clearance for papillary thyroid cancer.
Sadowski BM; Snyder SK; Lairmore TC
Surgery; 2009 Oct; 146(4):696-703; discussion 703-5. PubMed ID: 19789029
[TBL] [Abstract][Full Text] [Related]
19. Thyroglobulin before ablation and correlation with posttreatment scanning.
de Rosário PW; Guimarães VC; Maia FF; Fagundes TA; Purisch S; Padrao EL; Rezende LL; Barroso AL
Laryngoscope; 2005 Feb; 115(2):264-7. PubMed ID: 15689747
[TBL] [Abstract][Full Text] [Related]
20. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study.
Son YI; Jeong HS; Baek CH; Chung MK; Ryu J; Chung JH; So YK; Jang JY; Choi J
Ann Surg Oncol; 2008 Jul; 15(7):2020-6. PubMed ID: 18459004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
